18.12.2012 Views

Myeloid Leukemia

Myeloid Leukemia

Myeloid Leukemia

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

292 Lion and Watzinger<br />

and thus compromise the analysis of chimerism. There is currently no clear explanation<br />

for this phenomenon. If this problem is observed, a feasible approach<br />

to its elimination is having primers for each microsatellite locus labeled with<br />

different fluorescent dyes and selecting a primer/dye combination that does not<br />

show any interference between the specific alleles of the marker used and the<br />

dye-associated peak positions.<br />

20. In addition to the occurrence of nonspecific peaks, as outlined in Notes 13 and<br />

17–19, other problems may lead to the appearance of extra signals. Conversely,<br />

the problem of faint or absent peaks may also occur. Some of the common causes<br />

and possible measures are listed in Table 2.<br />

21. Only a limited number of highly polymorphic microsatellite loci need to be tested<br />

to provide an informative marker in virtually all donor/recipient constellations.<br />

In matched sibling and haploidentical transplants, more markers are generally<br />

required in order to differentiate between donor and recipient cells as compared<br />

to the unrelated setting. The screening panels used at most centers include 6–15<br />

microsatellite markers. Genotyping with a panel of 3–7 markers is often sufficient<br />

to reveal allelic differences between recipient- and donor-derived cells suitable<br />

for the analysis of chimerism.<br />

22. The criteria for the selection of informative markers are not uniformly defined<br />

(21). Ideally, at least one unique donor and recipient allele should be present to<br />

render a marker eligible for chimerism testing. For the monitoring of residual<br />

recipient hematopoiesis only, the presence of a unique recipient allele distinguishable<br />

from the donor allele(s) could be regarded as the minimum requirement.<br />

23. As a result of preferential amplification of short fragments during PCR cycling,<br />

minor recipient cell populations may be detected with greater sensitivity if the<br />

informative recipient alleles are shorter in length than any donor allele. Although<br />

microsatellite markers usually show relatively small differences in length<br />

between alleles, amplification efficiencies may nevertheless differ significantly<br />

and therefore have an impact on the sensitivity of the assays.<br />

24. Investigation of a posttransplant DNA sample with multiple microsatellite markers<br />

may improve the reproducibility and accuracy of quantitative chimerism<br />

analysis. The accuracy of quantitative chimerism assays can be increased by testing<br />

each sample with more than one marker and calculating mean values (18).<br />

Some investigators therefore perform clinical testing of chimerism with commercial<br />

multiplex kits facilitating co-amplification of several microsatellite markers<br />

in a single PCR reaction (16). However, the advantages indicated above are<br />

counterbalanced by significantly higher cost of consumables and lower sensitivity<br />

resulting from the high number of different fragments co-amplified. Most<br />

diagnostic centers therefore rely on the use of singleplex PCR reactions for chimerism<br />

analysis. Multiplex PCR assays are sometimes used for initial recipient/<br />

donor genotyping to select one or more informative markers for the monitoring of<br />

chimerism. If posttransplant DNA samples are tested by more than one microsatellite<br />

marker, amplification is usually performed in separate PCR reactions.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!